3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
13
Burkitt Lymphoma
9
Lung Neoplasms
7
Lymphoma, Non-Hodgkin
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Myeloid, Acute
5
Carcinoma, Non-Small-Cell Lung
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma
4
Hodgkin Disease
4
Sarcoma, Ewing
3
Recurrence
3
Plasmablastic Lymphoma
3
Multiple Myeloma
3
Lymphoma, B-Cell
3
Leukemia
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Immunoblastic Lymphadenopathy
2
HIV Infections
2
Ganglioneuroblastoma
2
Congenital Abnormalities
2
Central Nervous System Neoplasms
2
Interventions
Specimen Handling
3
pembrolizumab
2
Magnetic Resonance Spectroscopy
2
Doxorubicin
2
Biopsy
2
talimogene laherparepvec
1
peposertib
1
liposomal doxorubicin
1
fludarabine
1
aldesleukin
1
X-Rays
1
Radiotherapy
1
Radiation
1
Nivolumab
1
Ipilimumab
1
Histamine H2 Antagonists
1
Famotidine
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Etoposide
×
30 days
×
Clear all
No trials found.